Patent details

EP1487818 Title: ALKYLAMMONIUM SALTS OF OMEPRAZOLE AND ESOMEPRAZOLE

Basic Information

Publication number:
EP1487818
PCT Application Number:
PCT/SE/2003/000378
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037072790
PCT Publication Number:
WO/2003/074514
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ALKYLAMMONIUM SALTS OF OMEPRAZOLE AND ESOMEPRAZOLE
French Title of Invention:
SELS D'ALKYLAMMONIUM D'OMEPRAZOLE ET D'ESOMEPRAZOLE
German Title of Invention:
ALKYLAMMONIUMSALZE VON OMEPRAZOL UND ESOMEPRAZOL
SPC Number:

Dates

Filing date:
04/03/2003
Grant date:
30/05/2007
EP Publication Date:
30/05/2007
PCT Publication Date:
12/09/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/12/2004
EP B1 Publication Date:
30/05/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
04/03/2012
Expiration date:
04/03/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/03/2003
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
VAN MALDEREN MICHEL
From:
12/06/2007
Address:
ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
To:

Inventor

Name:
DAHLSTRÖM Mikael
Address:
Sweden (SE)

Priority

Priority Number:
362187 P
Priority Date:
05/03/2002
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 401/12;
Filing date Document type Number of pages